
Massive Bio
An AI-driven platform connecting cancer patients to bio-pharmaceutical clinical trials.
Targeted cancer therapies • Cancer genomics • Tumor profiling technologies • Clinical trial selection • Second Opinion

51 - 200
🔥 Funding within the last year
💰 $16.5M Series B on 2022-12